Sep 28, 2021 | Corona virus, Immunology, protection
Pfizer unveils oral inhibitorPF-07321332 of SARS-CoV-2 main protease Pfizer presented at a meeting of the AmericanChemical Society a potential anti-SARS-CoV-2 drug (PF-07321332), the firstorally administered coronavirus-specific protease inhibitor. CompoundPF-07321332...
Jul 6, 2021 | Corona virus, Immunology, protection
Drug repurposing strategy identified over a dozen existing drugs as potential COVID-19 therapies Although effective vaccines against COVID-19 already exist, the lack of effective antiviral drugs that can prevent SARS-CoV-2 virus infection or stop the development of...
Recent Comments